Guardant Health
Generated by Meeveem AI
"Conquering cancer through precision blood tests and data-driven insights"
Palo Alto, CA
•1000+ Employees
•Diagnostics
About Guardant Health
Guardant Health pioneers liquid biopsy technology that transforms cancer detection and treatment. Their blood-based tests analyse circulating tumor DNA to help doctors make informed decisions across all cancer stages. With over 500,000 tests performed by 12,000 physicians, their solutions uncover critical biomarkers that improve clinical outcomes for patients worldwide. Precision oncology redefines cancer care through personalized, data-driven approaches. Guardant's tests inform treatment selection, assess therapy response, detect remaining disease, and identify early cancer signs. This empowers healthcare professionals to give patients more time free from cancer through earlier detection and targeted interventions.
2506
Team Members
2011
Founded
Diagnostics
Sector
Hybrid
Work Environment
Our Vision
A world where cancer is detected at its earliest, most treatable stages, giving every person more time to live healthier lives free from the burden of disease through the transformative power of blood-based precision medicine.
Our Mission
Conquering cancer globally through the use of proprietary blood tests, vast data sets, and advanced analytics to transform patient care and empower doctors with critical insights.